Earlier in January, Recursion Pharmaceuticals updated investors at the JP Morgan Healthcare Conference on its AI-powered drug discovery platform, clinical programs, and collaborations with partners ...
Integrated Biosciences has a new Chief Scientific Officer (CSO), naming Daniel J. Anderson, PhD, to the post. Anderson joins ...
Integrated Biosciences, a biotechnology company combining synthetic biology, chemistry, and AI to discover small-molecule therapeutics for age-related diseases, today announced the appointment of ...
Leaders don’t fail from complexity overload. They fail from pretending it’s simple, then engineering systems that move ...
Q4 2025 Earnings Call January 22, 2026 5:00 PM ESTCompany ParticipantsJohn Pitzer - Corporate Vice President of Corporate ...
Explore how real estate tokenization works through smart contract architecture, enabling secure, transparent property ...
I should have been more careful before I clicked and opened the invitation on my computer. It was from my friend Adrienne, ...
The Mila artificial intelligence institute in Quebec is raising a US$100-million venture capital fund with plans to invest in more than 55 early-stage AI companies, in partnership with Inovia Capital ...
Modern cells are complex chemical entities with cytoskeletons, finely regulated internal and external molecules, and genetic material that determines ...
Odd News on MSN
Museum of personal failure opens in Vancouver, immediately achieves stated mission for founder
Burnaby man builds monument to romantic collapse; mother contributes wedding dress.
Ricursive joins Recursive and Unconventional AI in raising massive funds at multi-billion valuations out of the gate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results